Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond.
Saghir Ali, Xiaochen Tian, Kathryn A. Cunningham, Jia Zhou
J Med Chem May 1, 2025 DOI: 10.1021/acs.jmedchem.5c01156 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Citations | 5 |
| Key findings | The 5-HT2A receptor is a promising target for developing psychedelic drugs and potential treatments for psychiatric disorders, though separating therapeutic from hallucinogenic effects remains a challenge. |
Abstract
Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond.